3-methoxy-4-(4-methyl-1H-imidazol-1-yl)aniline → HCID 57829763, compound
Reaction equation
[CH3:1][N:2]([CH3:22])[C:3]([C:5]1[CH:10]=[C:9]([C:11]2[CH:16]=[CH:15][C:14]([C:17]([F:20])([F:19])[F:18])=[CH:13][CH:12]=2)[N:8]=[C:7](Cl)[N:6]=1)=[O:4].[CH3:23][O:24][C:25]1[CH:26]=[C:27]([NH2:37])[CH:28]=[CH:29][C:30]=1[N:31]1[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]1>>[CH3:1][N:2]([CH3:22])[C:3]([C:5]1[CH:10]=[C:9]([C:11]2[CH:16]=[CH:15][C:14]([C:17]([F:20])([F:19])[F:18])=[CH:13][CH:12]=2)[N:8]=[C:7]([NH:37][C:27]2[CH:28]=[CH:29][C:30]([N:31]3[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]3)=[C:25]([O:24][CH3:23])[CH:26]=2)[N:6]=1)=[O:4]Participants
3
Procedure
Using in analogous manner the procedure described in example 1e), 2-chloro-6-(4-trifluoromethyl-phenyl)-pyrimidine-4-carboxylic acid dimethylamide (99 mg, 0.3 mmol) was reacted with 3-methoxy-4-(4-methyl-imidazol-1-yl)-phenylamine (61 mg, 0.3 mmol) to give the title compound as yellow solid (76 mg, 51%). MS ISP (m/e): 497.4 [(M+H)+]. 1H NMR (CDCl3, 300 MHz): δ (ppm)=8.21 (d, 2H), 7.77 (d, 2H), 7.74 (d, 1H), 7.66 (s, 1H), 7.45 (s, 1H), 7.41 (s, 1H), 7.23 (d, 1H), 7.18 (dd, 1H), 6.90 (s, 1H), 3.89 (s, 3H), 3.18 and 3.15 (2 s, 2×3H), 2.31 (s, 3H).
Sources & evidence
- ORD record
- ord-08e57157dedc4dd1bf636147d37d6c9b
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08962834B2
Reaction notes
Loading…